KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 86 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $652,000 | +3.5% | 108,884 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $630,000 | -37.7% | 107,949 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $1,011,000 | -47.6% | 107,949 | -4.8% | 0.00% | -40.0% |
| Q3 2018 | $1,930,000 | +0.2% | 113,349 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,926,000 | +66.2% | 113,349 | +31.2% | 0.01% | +66.7% |
| Q1 2018 | $1,159,000 | +47.8% | 86,376 | +5.8% | 0.00% | +50.0% |
| Q4 2017 | $784,000 | -9.7% | 81,670 | +3.3% | 0.00% | -33.3% |
| Q3 2017 | $868,000 | +24.4% | 79,055 | +2.5% | 0.00% | +50.0% |
| Q2 2017 | $698,000 | -26.2% | 77,105 | +4.6% | 0.00% | -33.3% |
| Q1 2017 | $946,000 | +32.7% | 73,685 | -2.9% | 0.00% | +50.0% |
| Q4 2016 | $713,000 | – | 75,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |